289 related articles for article (PubMed ID: 31238605)
21. Global progress toward universal childhood hepatitis B vaccination, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
Cui F; Luo H; Wang F; Zheng H; Gong X; Chen Y; Wu Z; Miao N; Kane M; Hennessey K; Hadler SC; Hutin YJ; Liang X; Yang W
Vaccine; 2013 Dec; 31 Suppl 9():J36-42. PubMed ID: 24331019
[TBL] [Abstract][Full Text] [Related]
23. [Identifying immunization strategy for preventing mother-to-child transmission of hepatitis B virus].
Li J; Lu Y; Wei KP; Zhang X
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):97-101. PubMed ID: 30818912
[TBL] [Abstract][Full Text] [Related]
24. World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.
Diarra B; Yonli AT; Ouattara AK; Zohoncon TM; Traore L; Nadembega C; Obiri-Yeboah D; Yara J; Pietra V; Ouedraogo P; Bougouma A; Sanogo R; Simpore J
Virol J; 2018 Aug; 15(1):121. PubMed ID: 30081915
[TBL] [Abstract][Full Text] [Related]
25. Achieving ultimate control of hepatitis B infection in China: progress and challenges.
Jia JD; Yao GB
J Viral Hepat; 2010 Mar; 17 Suppl 1():2-3. PubMed ID: 20586927
[No Abstract] [Full Text] [Related]
26. Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models.
de Villiers MJ; Gamkrelidze I; Hallett TB; Nayagam S; Razavi H; Razavi-Shearer D
PLoS One; 2020; 15(8):e0237525. PubMed ID: 32776972
[TBL] [Abstract][Full Text] [Related]
27. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
[TBL] [Abstract][Full Text] [Related]
28. Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges.
Howell J; Lemoine M; Thursz M
J Viral Hepat; 2014 Jun; 21(6):381-96. PubMed ID: 24827901
[TBL] [Abstract][Full Text] [Related]
29. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
30. Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 May; 56(18):441-5. PubMed ID: 17495790
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005-2015.
He H; Zhou Y; Xie S
Vaccine; 2017 Aug; 35(36):4702-4706. PubMed ID: 28750855
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
Wang WL; Shu ZJ; Zhou LX; Zhao YR
Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.
Nelson NP; Easterbrook PJ; McMahon BJ
Clin Liver Dis; 2016 Nov; 20(4):607-628. PubMed ID: 27742003
[TBL] [Abstract][Full Text] [Related]
34. Research gaps in viral hepatitis.
Boyd A; Duchesne L; Lacombe K
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25054. PubMed ID: 29633564
[TBL] [Abstract][Full Text] [Related]
35. A model program for hepatitis B vaccination and education of schoolchildren in rural China.
Chen JJ; Chang ET; Chen YR; Bailey MB; So SK
Int J Public Health; 2012 Jun; 57(3):581-8. PubMed ID: 21845405
[TBL] [Abstract][Full Text] [Related]
36. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
Goyal A; Murray JM
Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B immunisation leads to the decline of hepatitis B virus prevalence in Gansu province, China.
Liu C; Li H; Gao L; Li F; Liang X; Yang K
Aust N Z J Public Health; 2011 Feb; 35(1):91-2. PubMed ID: 21299712
[No Abstract] [Full Text] [Related]
38. A hepatitis B-free generation in China: from dream to reality.
Fan R; Yin X; Liu Z; Liu Z; Lau G; Hou J
Lancet Infect Dis; 2016 Oct; 16(10):1103-1105. PubMed ID: 27676339
[No Abstract] [Full Text] [Related]
39. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
40. Modeling the transmission dynamics and control of hepatitis B virus in China.
Zou L; Zhang W; Ruan S
J Theor Biol; 2010 Jan; 262(2):330-8. PubMed ID: 19822154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
